KemPharm, Inc. IPO Research Information

KemPharm, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on KemPharm, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
KemPharm, Inc.	KMPH - NASDAQ	$12.00-$14.00	$11.00	$11.75	5.09 million	4/16/2015
Underwriter(s): Cowen & Co., RBC Capital Markets
Co-Manager(s): Canaccord Genuity, Oppenheimer & Co.
Industry: Health Care
Filing(s): Filed 2015-03-11 Terms Added 2015-04-03

KemPharm, Inc. Quote & Chart - Click for current quote - KMPH

About KemPharm, Inc. (adapted from KemPharm, Inc. prospectus):
They are a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that they believe will be improved versions of widely prescribed, approved drugs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "KMPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.